CryoPort Inc. (CYRX) Financial Statements (2024 and earlier)

Company Profile

Business Address 112 WESTWOOD PLACE, SUITE 350
BRENTWOOD, TN 37027
State of Incorp. NV
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments523,323628,79993,31794,29647,25815,042
Cash and cash equivalents36,595139,10136,87347,23537,32715,042
Short-term investments486,728489,69856,44447,0619,931 
Receivables43,85839,41231,3777,0983,5441,625
Inventory, net of allowances, customer advances and progress billings27,67816,50110,535474221115
Inventory27,67816,50110,535474221115
Other undisclosed current assets9,3178,80411,9281,097752516
Total current assets:604,176693,516147,157102,96551,77517,299
Noncurrent Assets
Finance lease, right-of-use asset, after accumulated amortization   27971
Operating lease, right-of-use asset26,87720,67514,0444,460
Property, plant and equipment63,60349,02930,03611,8334,3572,511
Intangible assets, net (including goodwill)342,126348,381359,19016,17713791
Goodwill151,117146,954145,28211,000  
Intangible assets, net (excluding goodwill)191,009201,427213,9085,17813791
Deferred income tax assets    
Other noncurrent assets 947419794   
Other undisclosed noncurrent assets1,017950905 351363
Total noncurrent assets:434,570419,454405,24832,5424,8462,965
TOTAL ASSETS:1,038,7461,112,970552,405135,50656,62020,264
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:28,04628,58324,8442,4981,7091,260
Employee-related liabilities9,9127,4411,9041,262926
Accrued liabilities8,458     
Other undisclosed accounts payable and accrued liabilities19,58818,67117,403595447334
Deferred revenue439547445368
Debt188615969123 
Business combination, contingent consideration, liability      
Other undisclosed current liabilities12,17813,4549,6721,9041,329926
Total current liabilities:40,85142,64535,0205,4603,0612,185
Noncurrent Liabilities
Long-term debt and lease obligation407,279423,452128,6294,11014,745 
Long-term debt, excluding current maturities407,063405,257116,256 14,712 
Capital lease obligations33 
Finance lease, liability216511129
Liabilities, other than long-term debt30,1014,3166,05821267192
Deferred revenue and credits192
Deferred rent credit     267
Deferred income tax liabilities4,9294,0185,88221
Other liabilities451298176   
Operating lease, liability24,72118,14412,2614,101
Business combination, contingent consideration, liability      
Other undisclosed noncurrent liabilities 4,677729    
Total noncurrent liabilities:442,057428,497134,6874,13115,012192
Total liabilities:482,908471,142169,7079,59118,0742,377
Equity
Equity, attributable to parent, including:555,838641,828382,698126,28138,54717,887
Common stock485040373026
Additional paid in capital1,114,8961,100,287566,451285,609179,502149,294
Accumulated other comprehensive income (loss)  5,376(45)3 
Accumulated deficit(542,832)(467,541)(192,013)(159,320)(140,988)(131,433)
Other undisclosed equity, attributable to parent(16,274)9,0322,844   
Total equity:555,838641,828382,698126,28138,54717,887
TOTAL LIABILITIES AND EQUITY:1,038,7461,112,970552,405135,87356,62020,264

Income Statement (P&L) ($ in thousands)

12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Revenues237,277222,60878,69633,94219,62611,954
Revenue, net11,954
Cost of revenue(133,404)(126,031)(42,362)(16,590)(9,386)(5,988)
Gross profit:103,87396,57736,33417,35210,2405,966
Operating expenses(135,777)(114,406)(66,344)(35,027)(18,885)(13,859)
Operating loss:(31,904)(17,829)(30,010)(17,675)(8,645)(7,893)
Nonoperating income (expense)(3,190)(256,013)(2,728)501(891)(172)
Investment income, nonoperating8,4743,253761(274) (186)
Other nonoperating income (expense)(5,522)(2,823)(929)7727814
Interest and debt expense(6,142)(251,754)(2,560)(1,367)(69)(16)
Other undisclosed income from continuing operations before equity method investments, income taxes   2,56027269186
Loss from continuing operations before equity method investments, income taxes:(41,236)(525,596)(32,738)(18,270)(9,536)(7,894)
Other undisclosed income (loss) from continuing operations before income taxes6,142251,754    
Loss from continuing operations before income taxes:(35,094)(273,842)(32,738)(18,270)(9,536)(7,894)
Income tax expense (benefit)(2,239)(1,686)45(62)(20)(5)
Loss from continuing operations:(37,333)(275,528)(32,693)(18,331)(9,556)(7,899)
Loss before gain (loss) on sale of properties:(275,528)(32,693)(18,331)(9,556)(7,899)
Net loss attributable to parent:(37,333)(275,528)(32,693)(18,331)(9,556)(7,899)
Other undisclosed net loss available to common stockholders, basic(8,000)(8,196)(42,336)   
Net loss available to common stockholders, diluted:(45,333)(283,724)(75,029)(18,331)(9,556)(7,899)

Comprehensive Income ($ in thousands)

12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net loss:(37,333)(275,528)(32,693)(18,331)(9,556)(7,899)
Comprehensive loss:(37,333)(275,528)(32,693)(18,331)(9,556)(7,899)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(33,306)(6,619)5,421(48)3 
Comprehensive loss, net of tax, attributable to parent:(70,639)(282,147)(27,272)(18,380)(9,552)(7,899)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: